UEF0:XETRA:XETRA-UBS Barclays US Liquid Corporates UCITS hedged to EUR A-acc (EUR)

ETF | Others |

Last Closing

USD 17.493

Change

+0.05 (+0.30)%

Market Cap

USD 0.36B

Volume

1.18K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.34 (+0.68%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.11 (+0.69%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.18 (+0.69%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.17 (+0.60%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.30 (+1.23%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.13 (+0.28%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

+1.44 (+1.02%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.31 (+0.61%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.48 (+0.49%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.02 (+0.54%)

USD 80.38B

ETFs Containing UEF0:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.96% 42% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.96% 42% F 45% F
Trailing 12 Months  
Capital Gain 10.07% 51% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.07% 50% F 52% F
Trailing 5 Years  
Capital Gain -5.75% 23% F 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.75% 22% F 27% F
Average Annual (5 Year Horizon)  
Capital Gain -3.44% 14% F 17% F
Dividend Return -3.44% 13% F 16% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 8.38% 65% D 73% C
Risk Adjusted Return -41.05% 16% F 16% F
Market Capitalization 0.36B 58% F 52% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.